# Naloxone

## Naloxone inj 0.4mg/1mL

##### 

| Title              | Content                                                                                                                                                                                                                                                  |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | INAL                                                                                                                                                                                                                                                     |
| Indications        | Complete or partial reversal of narcotic depression including respiratory depression， induced by opioids including natural & synthetic narcotics & narcotic-antagonist analgesics. Diagnosis of suspected acute opioid overdosage                       |
| Dosing             | (Micromedex) Overdose of opiate， known or suspected: (Injection solution) 0.4-2 mg IV， repeat every 2-3 minutes as needed; if no response after 10 mg， reconsider diagnosis of opioid toxicity; may administer IM or subQ if IV route is unavailable. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                            |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                            |
| Contraindications  | No Data                                                                                                                                                                                                                                                  |
| Adverse Effects    | Hypertension， hypotension， ventricular tachycardia， pulmonary oedema， tremulousness， nausea/vomiting， sweating.                                                                                                                                    |
| Pregnancy          | No Data                                                                                                                                                                                                                                                  |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                            |

